Phenylacetylglutamine|CAS 28047-15-6|DC Chemicals

Cas No.:	28047-15-6
Chemical Name:	Phenylacetyl L-Glutamine
Synonyms:	(S)-5-Amino-5-oxo-2-(2-phenylacetamido)pentanoic acid;Phenylacetyl L-Glutamine;L-Glutamine,N2-(2-phenylacetyl)-;Phenylacetyl L-Gluta;Phenylacetylglutamine;Phenylac-Gln-OH;(2S)-5-amino-5-oxo-2-[(2-phenylacetyl)amino]pentanoic acid;N(2)-phenylacetyl-L-glutamine;Phenylacetyl-L-glutamine;PA-L-Glutamine;alpha-N-Phenylacetyl-L-glutamine;L-N(sup 2)-(Phenylacetyl)glutamine;L-Glutamine, N2-(phenylacetyl)-;Glutamine, N2-(phenylacetyl)-, L-;JFLIEFSWGNOPJJ-JTQLQIEISA-N;N(2)-(phenylacetyl)-L-glutamine;92358I79RG;Glutamine, N(sup 2)-(phenylacetyl)-, L-;N2-phenylacetyl-L-;CHEBI:17884;CS-0031369;BRN 2593680;ANTINEOPLASTON AS2-1 COMPONENT PHENYLACETYLGLUTAMINE;DTXSID90182324;PHENYLACETYLGLUTAMINE [WHO-DD];NSC 203800;L-N(sup 2)-(Phenylacetyl);ANTINEOPLASTON AS 2-1 COMPONENT PHENYLACETYLGLUTAMINE;DS-16807;PHENYLACETYLGLUTAMINE [MI];PhenylAc-Gln-OH, AldrichCPR;C04148;(2S)-4-carbamoyl-2-(2-phenylacetamido)butanoic acid;MFCD01725188;N-Phenylacetyl-L-glutamine (Phenylacetylglutamine);NSC-203800;Phenyl-Ac-Gln-OH;S6076;ASTUGENAL COMPONENT PHENYLACETYLGLUTAMINE;AKOS010385089;1ST15417;A819301;UNII-92358I79RG;(S)-5-Amino-5-oxo-2-(2-phenylacetamido)pentanoicacid;HY-W050026;28047-15-6;Q7181415;FD21545;SCHEMBL236527;CHEMBL4303372;NS00014900;N2-(2-Phenylacetyl)-L-glutamine;3-09-00-02227 (Beilstein Handbook Reference);BRD-K70592483-001-01-0
SMILES:	OC([C@H](CCC(N)=O)NC(CC1C=CC=CC=1)=O)=O
Formula:	C₁₃H₁₆N₂O₄
M.Wt:	264.277143478394
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.